Delivery Order 75F40119D10019-75F40124F19020
- Not listed
- The Food and Drug Administration (FDA) awarded a delivery order valued at $677,149.50 to Elocen Global Technology, LLC for move and labor services involving the relocation of approximately 1,200 to 1,500 move units, with a completion deadline of December 29, 2025. This delivery order was issued under a competitive 8(a) set-aside program, which is reserved for small disadvantaged businesses, and employs firm fixed-price pricing. Elocen Global Technology, LLC is a minority-owned, woman-owned,...
- Elocen Global Technology, LLC, a minority-owned, woman-owned, and service-disabled veteran-owned small business based in Lanham, Maryland, has been awarded a delivery order valued at $181,498.24 for program and planning management support related to move and labor services for the Food and Drug Administration (FDA). The award, issued on March 24, 2025, is set aside for competitive 8(a) certified small businesses and falls under a larger $50 million indefinite delivery/indefinite quantity...
- This is a firm fixed-price delivery order contract awarded by the Food and Drug Administration (FDA) to Elocen Global Technology, LLC, a minority-owned small business. The contract, worth $523,161.76, is for move and labor services to support the FDA's Center for Food Safety and Applied Nutrition (CFSAN) facilities in Berwyn Heights, Maryland. The contract has a period of performance through May 18, 2025. Elocen Global Technology has received over $15 million in prior contracts from the FDA to...
- The Food and Drug Administration awarded a delivery order valued at $798,736.08 to Elocen Global Technology, LLC for move and labor services focused on loading dock management at the FDA's White Oak Campus in Lanham, Maryland. The contract is structured as a firm fixed-price delivery order under a larger 8(a) set-aside indefinite delivery/indefinite quantity (IDIQ) vehicle and is scheduled for completion by December 29, 2025. The award was made on March 24, 2025, under the Competitive 8(a)...
- This is a delivery order issued by the Food and Drug Administration (FDA), a civilian federal agency, to Elocen Global Technology, LLC, a minority-owned small business. The order, valued at $308,880.00 over 12 months, is for FDA small move units and related services. It is part of a larger $2,378,465.00 indefinite delivery/indefinite quantity (IDIQ) contract held by Elocen to provide facility relocations, furniture moving, shipments, and related labor support to the FDA through 2024. The...
- The Department of Health and Human Services Food and Drug Administration awarded a $61,268 firm fixed price delivery order to Elocen Global Technology LLC, doing business as Elocen Global Technology LLC. The order is against the CTP-2022-111655 contract vehicle to provide shredding services and labor at the FDA's non-White Oak campus location in Lanham, Maryland as part of the agency's move. Elocen Global Technology LLC will deliver shredding and related move support from May 2022 through June...
- The Food and Drug Administration (FDA) awarded a delivery order valued at $105,316.34 to Elocen Global Technology, LLC, a minority-owned, small disadvantaged, woman-owned, and service-disabled veteran-owned business based in Lanham, Maryland. This delivery order, issued under a larger $50 million Competitive 8(a) set-aside indefinite delivery/indefinite quantity (IDIQ) contract, covers non-White Oak Campus FDA shredding services for the Office of Compliance within the Center for Drug...
- The Department of Health and Human Services' Food and Drug Administration awarded a $381,311 delivery order contract to Elocen Global Technology, LLC for move and labor services in Silver Spring, Maryland. As a small business, Elocen will provide relocation assistance to the FDA's Center for Biologics Evaluation and Research facilities from April 2020 through October 2020 on a firm fixed price basis. No major subcontractors or set aside designations were indicated. This delivery order was issued...
- This is a $212,892.83 firm-fixed-price delivery order contract awarded by the Department of Health and Human Services' Food and Drug Administration (FDA) to Elocen Group, LLC, a woman-owned small business. The contract is a competitive 8(a) set-aside and supports the FDA in Bethesda, Maryland. Elocen Group, a Washington, D.C.-based company, provides program and project management services in the built environment. The award date was May 29, 2015, with a completion date of January 1, 2016....
- <p>The Department of Health and Human Services Food and Drug Administration awarded a $171,064 firm fixed price delivery order to Elocen Global Technology, LLC for move and labor services in Texas. Elocen Global Technology LLC will provide move and labor services in Dallas, Texas to support the FDA's operations. The period of performance is from July 22, 2020 through September 30, 2020. No additional details were provided regarding the original solicitation or use of a contract vehicle.</p>
- 75F40119D10019Indefinite Delivery Contract
- 75F40119D10019-75F40124F19020Delivery Order
The Food and Drug Administration awarded a $885,480.40 firm fixed-price delivery order to Elocen Global Technology, LLC for move and labor services supporting the agency's headquarters consolidation project. This competitive 8(a) set-aside contract, issued on September 9, 2024, encompasses move management and move unit services with an ultimate completion date of November 15, 2025. The work will be performed in Lanham, Maryland, where the awardee maintains its principal operations. Elocen Global Technology is a minority-owned, small disadvantaged, woman-owned, and service-disabled veteran-owned small business that has established a substantial track record with the FDA across multiple service categories. This delivery order is issued under Elocen Global Technology's existing $50 million 8(a) indefinite delivery/indefinite quantity contract vehicle with the FDA. The contractor has consistently executed similar move management, warehouse operations, and facilities support services for the agency without utilizing subcontractors. The headquarters consolidation project represents a continuation of the company's core competencies in managing complex logistical operations across FDA facilities, positioning the contractor to leverage existing operational knowledge and infrastructure to execute the required move management and labor services efficiently through the stated completion deadline.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00003 | Supplemental Agreement for work within scope | $0 | 9/19/25 | |
| P00002 | Other Administrative Action | $0 | 7/9/25 | |
| P00001 | Other Administrative Action | $0 | 9/20/24 | |
| Not listed | Not listed | $885.5k | 9/8/24 |